PELL Bio-Med Technology Co. Ltd. (6949.TW)

TWD 127.0

(-3.79%)

Inventory Summary of PELL Bio-Med Technology Co. Ltd.

  • PELL Bio-Med Technology Co. Ltd.'s latest annual inventory in 2023 was 3.76 Million TWD , down -17.84% from previous year.
  • PELL Bio-Med Technology Co. Ltd.'s latest quarterly inventory in 2024 Q2 was 4.64 Million TWD , up 68.21% from previous quarter.
  • PELL Bio-Med Technology Co. Ltd. reported annual inventory of 4.58 Million TWD in 2022, up 8.1% from previous year.
  • PELL Bio-Med Technology Co. Ltd. reported annual inventory of 4.23 Million TWD in 2021, down 0.0% from previous year.
  • PELL Bio-Med Technology Co. Ltd. reported quarterly inventory of 4.64 Million TWD for 2024 Q2, up 68.21% from previous quarter.
  • PELL Bio-Med Technology Co. Ltd. reported quarterly inventory of 3.76 Million TWD for 2023 Q4, up 10.74% from previous quarter.

Annual Inventory Chart of PELL Bio-Med Technology Co. Ltd. (2023 - 2021)

Historical Annual Inventory of PELL Bio-Med Technology Co. Ltd. (2023 - 2021)

Year Inventory Inventory Growth
2023 3.76 Million TWD -17.84%
2022 4.58 Million TWD 8.1%
2021 4.23 Million TWD 0.0%

Peer Inventory Comparison of PELL Bio-Med Technology Co. Ltd.

Name Inventory Inventory Difference
Apex Biotechnology Corp. 747.71 Million TWD 99.497%
Sinphar Pharmaceutical Co.,Ltd. 839.19 Million TWD 99.552%
Panion & Bf Biotech Inc. 538.09 Million TWD 99.301%
Chunghwa Chemical Synthesis & Biotech Co., Ltd. 1.21 Billion TWD 99.689%
GenMont Biotech Incorporation 88.11 Million TWD 95.73%
Abnova (Taiwan) Corporation 408.3 Million TWD 99.078%
Adimmune Corporation 526.4 Million TWD 99.285%
Tanvex BioPharma, Inc. 108.28 Million TWD 96.525%
Polaris Group 36.35 Million TWD 89.649%
Energenesis Biomedical CO.,LTD. 733 Thousand TWD -413.37%
UnicoCell Biomed Co., Ltd. 5.45 Million TWD 30.967%